Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 78.85% is in line with its 5-year average of 82.62%, around the middle of its 5-year range (68.96%–84.45%).
1.62% above its 12-month average of 77.59%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 68.96%.
GROSS MARGIN
78.85%
GROSS MARGIN AVG TTM
77.59%
GROSS MARGIN AVG 3Y
82.70%
GROSS MARGIN AVG 5Y
82.62%
GROSS MARGIN AVG 10Y
84.88%
GROSS MARGIN AVG 15Y
85.02%
GROSS MARGIN AVG 20Y
83.67%
CURRENT VS TTM AVG
+1.62%
CURRENT VS 3Y AVG
-4.65%
CURRENT VS 5Y AVG
-4.56%
CURRENT VS 10Y AVG
-7.11%
CURRENT VS 15Y AVG
-7.26%
CURRENT VS 20Y AVG
-5.76%
SECTOR MEDIAN · HEALTHCARE
41.76%
median of 631 covered companies
CURRENT VS SECTOR MEDIAN
+88.82%
vs the sector median at left
MiMedx Group, Inc.
Market Cap
$665.40M
Gross Margin
78.85%
TTM Avg
77.59%
3Y Avg
82.70%
5Y Avg
82.62%
Market Cap
$666.36M
Gross Margin
91.05%
TTM Avg
-190849.07%
3Y Avg
-96132.87%
5Y Avg
-64176.88%
Market Cap
$666.95M
Gross Margin
100.27%
TTM Avg
50.13%
3Y Avg
25.07%
5Y Avg
10.71%
Market Cap
$692.29M
Gross Margin
-16.57%
TTM Avg
15.14%
3Y Avg
17.91%
5Y Avg
27.64%
Market Cap
$635.69M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$704.02M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiMedx Group, Inc. (MDXG) | $665.40M | 78.85% | 77.59% | 82.70% | 82.62% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.36M | 91.05% | -190849.07% | -96132.87% | -64176.88% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | 100.27% | 50.13% | 25.07% | 10.71% |
| Annexon, Inc. (ANNX)vs › | $679.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| OmniAb, Inc. (OABI)vs › | $643.45M | -18.17% | 40.91% | 70.46% | 80.30% |
| Anteris Technologies Global Corp. (AVR)vs › | $692.29M | -16.57% | 15.14% | 17.91% | 27.64% |
| Climb Bio, Inc. (CLYM)vs › | $636.48M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aura Biosciences, Inc. (AURA)vs › | $635.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| Faeth Therapeutics, Inc. (FTH)vs › | $704.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $707.95M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
78.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 68.96% |
| 2026-03-31 | 70.56% |
| 2025-12-31 | 83.86% |
| 2025-09-30 | 83.54% |
| 2025-06-30 | 81.05% |
| 2025-03-31 | 81.23% |
| 2024-12-31 | 81.80% |
| 2024-09-30 | 81.77% |
| 2024-06-30 | 82.75% |
| 2024-03-31 | 84.45% |
| 2023-12-31 | 84.06% |
| 2023-09-30 | 81.90% |
| 2023-06-30 | 83.28% |
| 2023-03-31 | 82.67% |
| 2022-12-31 | 80.68% |
| 2022-09-30 | 81.99% |
| 2022-06-30 | 82.32% |
| 2022-03-31 | 83.13% |
| 2021-12-31 | 84.05% |
| 2021-09-30 | 83.94% |
| 2021-06-30 | 81.28% |
| 2021-03-31 | 83.92% |
| 2020-12-31 | 84.22% |
| 2020-09-30 | 84.00% |
| 2020-06-30 | 84.72% |
| 2020-03-31 | 83.76% |
| 2019-12-31 | 83.37% |
| 2019-09-30 | 85.14% |
| 2019-06-30 | 85.54% |
| 2019-03-31 | 88.85% |
| 2018-12-31 | 88.77% |
| 2018-09-30 | 91.54% |
| 2018-06-30 | 90.28% |
| 2018-03-31 | 88.88% |
| 2017-12-31 | 90.58% |
| 2017-09-30 | 88.65% |
| 2017-06-30 | 88.70% |
| 2017-03-31 | 87.96% |
| 2016-12-31 | 87.02% |
| 2016-09-30 | 87.59% |
| 2016-06-30 | 87.11% |
| 2016-03-31 | 85.11% |
| 2015-12-31 | 90.38% |
| 2015-09-30 | 89.84% |
| 2015-06-30 | 88.86% |
| 2015-03-31 | 87.37% |
| 2014-12-31 | 90.90% |
| 2014-09-30 | 90.01% |
| 2014-06-30 | 89.29% |
| 2014-03-31 | 84.78% |
| 2013-12-31 | 82.71% |
| 2013-09-30 | 86.89% |
| 2013-06-30 | 83.73% |
| 2013-03-31 | 83.52% |
| 2012-12-31 | 83.93% |
| 2012-09-30 | 82.08% |
| 2012-06-30 | 77.17% |
| 2012-03-31 | 74.13% |
| 2011-12-31 | 67.26% |
| 2011-09-30 | 60.81% |
| 2011-06-30 | 59.09% |
| 2011-03-31 | 36.86% |
| 2010-12-31 | -49.58% |
| 2010-09-30 | -399.59% |
| 2010-06-30 | -35.35% |
| 2010-03-31 | -230.49% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
